Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-02-13-Speech-2-137"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-02-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Deliberate release of GMOs into the environment2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20010213.7.2-137"2
lpv:hasSubsequent	lp_eu:2001-02-13-Speech-2-1382
lpv:speaker	lp:David Robert Bowe2
lpv:spoken text	". – Mr President, we are now close to the end of what has been a three-year process of reforming the legislation for the control and genetically modified use of organisms as products within the European Union. We have now completed the process of reconciliation and we have a text for final approval. The text before us meets many of Parliament's demands at first and second reading. We have the precautionary principle reaffirmed. We have tighter risk assessment of all GMO releases. We have schemes for monitoring traceability that will ensure continuous assessment of all releases throughout the ten-year life of this time-limitation for consents. We have achieved the phasing out of all harmful, antibiotic-resistant marker genes. We have a clear timetable. We have a clear and transparent process and a clear timetable for the approvals which ensure the mandatory consultation of the public which guarantees public registers of locations of GMOs grown and used. Steps have also been taken on the issues of liability, traceability and labelling. Parliament can only be satisfied on those issues, however, when we see the additional legislation and flanking measures which I understand are now in preparation within the Commission. In short, we have in front of us today for our approval the toughest GMO legislation in the world, so tough, in fact, that some natural foods in common use today would not pass through this procedure. Should we approve this legislation tomorrow it would mean the beginning of the end of the present informal 'moratorium' on GMO commercial approvals. Certain Members of the Council have, however, already made it clear that they will scrutinise individual applications for approval and may not allow commercialisation until legislation on traceability and labelling is in place. I welcome this. This is a final safeguard to the recommencement of an approval process which has been long awaited but it can be no reason for opposing the final approval of the new 90/220 legislation we have in front of us now. This legislation is an essential building block and foundation for the success of those measures still to come. I therefore commend this important legislation to the House. It is essential to ensure the safe and proper use of GMO products within the European Union. It is essential to ensure the building of public confidence in these products, it is essential to ensure that this new technology, which promises so much, will in the end deliver what we are seeking from it."@en1
lpv:spokenAs	member; PES (1999-07-20--2004-07-19)3 substitute; Committee on Industry, External Trade, Research and Energy (1999-07-22--2002-01-14)3 member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3 member; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)3 member; Delegation for relations with the People's Republic of China (1999-10-06--2002-01-14)3 unknown; Labour Party (1999-07-20--2004-07-19)3
lpv:unclassifiedMetadata	"Bowe (PSE ),"1 "rapporteur"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph